US OptionsDetailed Quotes

BCPC241115C210000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 5 09:30 ET

0.00High0.00Low

Balchem Stock Discussion

Moomoo AI

Jan 23 05:31

Balchem Corporation's market sentiment has improved, as seen in its P/E ratio of 45.01. Despite slower EPS growth, the company's long-term track record and dividends have led to a favorable total shareholder return.

Balchem's (NASDAQ:BCPC) 13% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period

Moomoo AI

Jan 4 13:35

The high P/E ratio for Balchem is down to investors foreseeing rapid growth outpacing the market. Despite slight falls, medium-term growth has pleased shareholders. Investors might pay more for the stock expecting strong future growth. This situation could maintain the stock's price.

With Balchem Corporation (NASDAQ:BCPC) It Looks Like You'll Get What You Pay For

Moomoo AI

Dec 20, 2023 13:02

Balchem's dedication to profit-sharing with shareholders is evident from its three-year median payout ratio of 21%. Yet, an enhancement in its ROE could prove beneficial, given the substantial reinvestment of profits. Expectations suggest an increase in company's earnings, despite its low ROE compared to the industry.

Balchem Corporation's (NASDAQ:BCPC) Stock Is Going Strong: Have Financials A Role To Play?

Moomoo AI

Oct 7, 2023 09:53

Despite lower-than-average share price increase, the market's consistent positive reception over the past five years suggests worthiness for long-term investments.

Investors in Balchem (NASDAQ:BCPC) Have Seen Notable Returns of 35% Over the Past Five Years

Moomoo Breakfast US

Aug 31, 2022 07:22

Columns Today's Pre-Market Stock Movers: HPQ, SNAP, CHWY, BBBY and More

Gapping up
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...

linuslin

May 1, 2021 05:48

From what I see FUTU

$Futu Holdings Ltd (FUTU.US)$
$Apple (AAPL.US)$
$Camtek (CAMT.US)$
$Balchem (BCPC.US)$
$Tesla (TSLA.US)$
From High Net Income Ratio, I consider FUTU still be good stock and speed growing company. We can consider it wont drop below 145 next week. the price between 145~150. we can consider to buy some share. please do not all in. it’s risk for doing this. see below the hourly and daily chart I sharing with your. Support still 138. daily Resistant at 180~185. If hourly can keep the price above 155, we can hold for it try the higher resistant at 180. Please make your investment at the good allocate fund management. My Chinese Investment guide video is coming soon. please see what I explain you to detail. Good Luck!
...

No comment yet